Sharma I I - OmicsDI

Show results for

Unknown (4522)
Transcriptomics (148)
Proteomics (102)
Genomics (33)
Metabolomics (12)
Other (1)

Organisms

Homo sapiens (107)
Mus musculus (41)
Drosophila melanogaster (18)
Rattus norvegicus (14)
Escherichia coli (7)
Oryza sativa (6)
Arabidopsis thaliana (6)
Zea mays (5)
Hordeum vulgare (3)
Salmonella enterica (2)
Ruegeria pomeroyi DSS-3 (2)
Geobacter sulfurreducens (2)
Salmonella enterica subsp. enterica serovar Typhimurium str. SL1344 (2)
Acinetobacter baumannii (2)
Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 (2)
Cereibacter sphaeroides (1)
Thermococcus kodakarensis KOD1 (1)
Neisseria lactamica 020-06 (1)
Stenotrophomonas maltophilia (1)
Eucalyptus camaldulensis (1)
Prochlorococcus marinus subsp. pastoris str. CCMP1986 (1)
marine metagenome (1)
Arachis hypogaea (1)
Leishmania donovani (1)
Brassica juncea (1)
Escherichia coli ETEC H10407 (1)
Oryza sativa Indica Group (1)
Medicago truncatula (1)
Campylobacter jejuni (1)
Pseudomonas putida (1)

Organisms

Agrobacterium fabrum str. C58 (2)
Campylobacter jejuni (1)
Homo sapiens (1)

Repository

biostudies-arrayexpress (162)
pride (79)
EGA (15)
MetaboLights (12)
MassIVE (10)
PanoramaPublic (6)
ENA (5)
geo (2)
iProX (2)
jPOST (2)
GPMDB (1)

Tissue

Cell culture (23)
Brain (7)
Melanocyte (5)
Blood cell (3)
Blood plasma (3)
Bone marrow (3)
Epithelial cell (3)
Macrophage (3)
Permanent cell line cell (3)
Tuber (3)
Blood (2)
Early embryonic cell (2)
Kidney (2)
Kidney cell (2)
Lung (2)
Root (2)
B cell (1)
Cell line cell (1)
Common myeloid progenitor (1)
Culture condition: dark grown cells (1)
Epithelial cell of cervix (1)
Fibroblast (1)
HEK-293T cell (1)
Heart (1)
HiPSC cell (1)
Leaf (1)
Medulloblastoma cell (1)
Plant cell (1)
Plasma cell (1)
T cell (1)

Disease

Melanoma (5)
Acute leukemia (2)
Brain cancer (2)
Breast cancer (2)
Cervix carcinoma (2)
Disease free (2)
Glioblastoma (2)
Huntington Disease (2)
Multiple myeloma (2)
DNA repair deficiency (1)
"hyperglycaemic, obese and insulin resistant" (1)
Not Available (1)
Brain glioblastoma multiforme (1)
Brain meningioma (1)
FTDALS1 (1)
Inflammation (1)
Leukemia (1)
Lymphoma (1)
Meningioma (1)
Monoclonal gammopathy of uncertain significance (1)
Multiple myeloma (1)
Myeloma (1)
Neuroblastoma (1)
Plasmodium malariae malaria (1)
Schizophrenia (1)
Uveal melanoma (1)

Technology Type

Mass Spectrometry (79)
Shotgun proteomics (55)
Mass spectrometry (11)
Affinity purification coupled with mass spectrometry proteomics (9)
Bottom-up proteomics (8)
Data-independent acquisition (6)
Data-dependent acquisition (4)
Gel-based experiment (3)
Chemical cross-linking coupled with mass spectrometry proteomics (2)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2500, ILLUMINA (1)
NMR spectroscopy (1)
DiaPASEF (1)
Olink affinity proteomics (1)
SRM/MRM (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (6)
Q Exactive (5)
Liquid Chromatography MS - positive - reverse phase (5)
Illumina NovaSeq 6000 (4)
NextSeq 500 (3)
NextSeq 2000 (2)
Illumina MiSeq (2)
Q Exactive HF (2)
4100A scanner (1)
Illumina HiSeq 1000 (1)
NextSeq 550 (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
Instrument (1)
LTQ Orbitrap Elite (1)
LTQ Orbitrap Velos (1)
Orbitrap Eclipse (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion Lumos ETD (Thermo Scientific instrument model) (1)
Bruker (1)
Flow injection analysis MS - (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
MS Imaging - (1)

Publication Date

2013 (24)
2015 (23)
2014 (23)
2023 (21)
2020 (17)
2010 (16)
2012 (15)
2022 (14)
2016 (14)
2008 (14)
2025 (13)
2024 (12)
2017 (12)
2021 (11)
2009 (9)
2026 (8)
2011 (8)
2007 (8)
2019 (8)
2005 (2)
2018 (2)

CHEBI ID

CHEBI:16811 (4)
CHEBI:18237 (4)
CHEBI:25094 (4)
CHEBI:29016 (4)
CHEBI:15354 (3)
CHEBI:15891 (3)
CHEBI:16027 (3)
CHEBI:16235 (3)
CHEBI:16449 (3)
CHEBI:16450 (3)
CHEBI:16704 (3)
CHEBI:17012 (3)
CHEBI:17126 (3)
CHEBI:17154 (3)
CHEBI:17405 (3)
CHEBI:17596 (3)
CHEBI:18243 (3)
CHEBI:22653 (3)
CHEBI:24898 (3)
CHEBI:27897 (3)
CHEBI:28044 (3)
CHEBI:28300 (3)
CHEBI:32816 (3)
CHEBI:37024 (3)
CHEBI:6650 (3)
CHEBI:133343 (2)
CHEBI:136623 (2)
CHEBI:137245 (2)
CHEBI:140768 (2)
CHEBI:15428 (2)

Metabolite Name

1,11-Undecanedicarboxylic acid (2)
4-Pyridoxic acid (2)
Ascorbic acid (2)
Ascorbyl palmitate (2)
Azelaic acid (2)
Dopamine (2)
Folic acid (2)
Glutamate (2)
Glutamine (2)
Hexadecanedioic acid (2)
Hydrocinnamic acid (2)
Indolelactic acid (2)
Methionine (2)
Pantothenic acid (2)
Phenol sulfate (2)
Serine (2)
Taurine (2)
Tetradecanedioic acid (2)
Tyrosol (2)
Undecanedioic acid (2)
Uridine (2)
(+)-(1R,2R)-1,2-Diphenylethane-1,2-diol (1)
(+)-Isoxanthochymol (1)
(+)-O-Methylarmepavine (1)
(+)-Setoclavine (1)
(+)-Zeylenol (1)
(+-)-(Z)-2-(5-Tetradecenyl)cyclobutanone (1)
(+-)-3-Hydroxynonanoic acid (1)
(+-)-Anisoxide (1)
(+-)-threo-1-(p-Hydroxyphenyl)propylene glycol 4'-glucoside (1)

First Public Date

2025 (2)
2020 (2)
2024 (1)

Classification

bacteria (1)

Study type

Transcription profiling by array (99)
RNA-seq of coding RNA (20)
Unknown experiment type (13)
ChIP-seq (9)
Other (4)
ChIP-chip by tiling array (3)
Antigen profiling (2)
DNA-seq (2)
Methylation profiling by high throughput sequencing (2)
RNA-seq of non coding RNA (2)
Proteomic profiling by mass spectrometer (1)
Transcription profiling by tiling array (1)
Bisulfite-seq (1)
Hi-C (1)
RNA-seq of coding RNA from single cells (1)
RNA-seq of total RNA (1)

Release Date

2022 (598)
2023 (569)
2021 (552)
2025 (499)
2024 (489)
2020 (402)
2019 (288)
2018 (239)
2017 (188)
2016 (170)
2015 (133)
2014 (119)
2013 (94)
2026 (76)
2012 (75)
2011 (53)
2010 (52)
2008 (32)
2009 (27)
2007 (12)
2005 (6)
2004 (3)
2006 (2)
2002 (2)
2003 (1)
2001 (1)
2000 (1)
1998 (1)

Lab affiliation

Moffitt Cancer Center Tampa, FL, USA (4)
Professor Institutt for kreftforskning og molekylær medisin Erling Skjalgssons g 1, Laboratoriesenteret * 231.05.036 Trondheim 7030, Norway (3)
Translational Genomics Research Institute (3)
University of Greifswald, Institute for Microbiology, Department for Microbial Proteomics (3)
Max Planck Institute for the Science of Light & Max-Planck-Zentrum für Physik und Medizin Division Biological Optomechanics Staudtstr. 2 91058 Erlangen Germany (2)
Molecular Oncology Chemical Biology and Molecular Medicine Moffitt Cancer Center & Research Institute, SRB3 12902 Magnolia Drive, Tampa, FL, 33612, USA. (2)
Professor i molekylærbiologi og faglig leder av PROMEC Institutt for klinisk og molekylær medisin Fakultet for medisin og helsevitenskap geir.slupphaug@ntnu.no 72573076 91825455 Laboratoriesenteret, 231.05.034, Øya, Erling Skjalgssons g 1 (2)
Assistant Professor, Department of Chemistry Assistant Professor, Department of Biology (by courtesy) Assistant Professor, Thomas C. Jenkins Department of Biophysics (by courtesy) Preceptor, Chemistry-Biology Interface (CBI) Program (1)
Assistant Professor, Department of Chemistry Assistant Professor, Thomas C. Jenkins Department of Biophysics (by courtesy) (1)
Associate Professor, The Swire Institute of Marine Sciences and School of Biological Sciences, The University of Hong Kong, Hong Kong (1)
Brigham and Women's Hospital (1)
Bristol Myers Squibb (1)
Center for Medical Genetics, Ghent University and University Hospital, Ghent, Belgium (1)
Chair of the LU Hemp Institute and an Assistant Professor of Molecular Biology and Genomics at Lincoln University in Missouri. (1)
Department of Biochemistry and Molecular Biology & The Center for Systems Biology University of Iceland Sturlugata 8, 101 Reykjavik Iceland. (1)
Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia (1)
Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia. (1)
Department of Biochemisty, The University of Western Ontario, London,Canada (1)
Department of Biomedical Sciences, University of Padova, Italy (1)
Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim 7034, Norway (1)
Department of Cancer Research and Molecular Medicine Faculty of Medicine Laboratory Centre, 5th floor. Erling Skjalgssons gt. 1 Norwegian University of Science and Technology NTNU 7006 Trondheim, Norway Tel: +47 72573076; Fax: +47 72576400 Cell. phone: +47 91825455 (1)
Department of Chemistry, Johns Hopkins University (1)
Department of Chemistry, University of California, Riverside 501 Big Springs Rd, Riverside, CA 92521 (1)
Dept of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Sweden (1)
Director Institute of Translational and Stratified Medicine, Plymouth University Peninsula Schools of Medicine and Dentistry, UK (1)
Director Institute of Translational and Stratified Medicine, Plymouth University Peninsula Schools of Medicine and Dentistry, UK. (1)
EMBL Grenoble (1)
ETH Zürich, SLA, Schorenstrasse 16, 8603 Schwerzenbach, Switzerland (1)
Functional Proteo-Metabolomics Institute of Biochemistry University of Innsbruck (1)
Global Health Institute EPFL Switzerland (1)

Tags

xref:PubMed:38897989 (1)
xref:PubMed:42529171 (1)
xref:PubMed:33560537 (1)
xref:PubMed:41064459 (1)
xref:PubMed:33093235 (1)
pathogen:bacterium (1)
pathogen (1)

Previous page
1 / 482
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 482
Next page

Sort by:

Relevance

Page size

Characterization of ND5 subunit of bovine mitochondrial NADH-ubiquinone oxidoreductase (complex I)

This project contains MALDI-TOF/TOF spectra derived from the ND5 subunit of bovine mitochondrial NADH-ubiquinone oxidoreductase (complex I).

ORGANISM(S): Bos Taurus

2022-07-29 | PXD031179 | JPOST Repository

Highly regioselective 6-exo-dig iodo/bromo cyclizations of functionalized 5-amino propargyl pyrimidinones: an efficient synthesis of functionalized pteridines.

Not available

S-EPMC10616752 | biostudies-literature

The cGAS-STING pathway drives type I IFN immunopathology in COVID-19

Syndrome Coronavirus 2 (SARS-CoV-2), is characterized by significant lung pathology and extrapulmonary complications. Type I interferons (IFNs) play an essential role in the pathogenesis of COVID-19. While rapid induction of type I IFNs limits virus propagation, sustained elevation of type I IFNs in...

ORGANISM(S): Homo sapiens (Human)

2022-04-04 | PXD030753 | Pride

HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain [spinal cord tissue]

Histone deacetylase inhibitors (HDACIs) interfere with the epigenetic process of histone acetylation and are known to have analgesic properties in models of chronic inflammatory pain. The aim of this study was to determine whether these compounds could also affect neuropathic pain. Different class I...

ORGANISM(S): Rattus norvegicus

2013-10-01 | E-GEOD-51294 | biostudies-arrayexpress

HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain [DRG tissue]

ORGANISM(S): Rattus norvegicus

2013-10-01 | E-GEOD-51295 | biostudies-arrayexpress

Comparative Study of Inlay and Overlay Cartilage Perichondrium Composite Graft Myringoplasty.

Not available

S-EPMC10188858 | biostudies-literature

Genetic changes of Plasmodium vivax tempers host tissue-specific responses in Anopheles stephensi.

Not available

S-EPMC9040150 | biostudies-literature

Expression of the transcription factor, TFII-I, during post-implantation mouse embryonic development.

Not available

S-EPMC2921380 | biostudies-literature

Primary transcriptome map of the hyperthermophilic archaeon ThermococcusM-BM- kodakarensis

Background: Prokaryotes have relatively small genomes, densely-packed and apparently dominated by protein-encoding sequences. However, data now generated by high throughput RNA sequencing (RNA-seq) reveal surprisingly more-complex transcriptomes with many previously unrecognized and unanticipated ...

ORGANISM(S): Thermococcus kodakarensis KOD1

2014-08-18 | E-GEOD-56262 | biostudies-arrayexpress

Sphingosine kinases negatively regulate the expression of matrix metalloproteases (MMP1 and MMP3) and their inhibitor TIMP3 genes via sphingosine 1-phosphate in extravillous trophoblasts.

Not available

S-EPMC8254167 | biostudies-literature

Previous page
1 / 482
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 482
Next page

Sort by:

Relevance

Page size

4818 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets